drugset / Trial / NCT00004142

Radiofrequency Ablation Followed By Hepatic Artery Chemotherapy in Treating Patients With Colorectal Cancer That Has Spread to the Liver

NCT00004142

NaSingle-groupOpen-labelTreatment

Summary

RATIONALE: Radiofrequency ablation may be able to shrink or destroy cancer cells. Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Chemotherapy delivered directly into the blood vessels of the liver may prevent new tumors from growing. Combining these therapies may be an effective treatment for colorectal cancer that has spread to the liver. PURPOSE: Phase II trial to study the effectiveness of radiofrequency ablation followed by chemotherapy delivered directly into the blood vessels of the liver in treating patients who have colorectal cancer that has spread to the liver.

Timeline

Start
1998-08-05
Primary completion
2003-12-09
Completion
2003-12-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Floxuridine Unknown Other
Subject fluorouracil Small molecule Other